Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


MAP is the leading global meeting dedicated to understanding molecular developments that can help in making cancer treatment more personalised.

The congress is at the interface between basic science and clinical application, and covers a broad range of tumours types, molecular targets and therapies.

By attending the Molecular Analysis for Precision Oncology Congress 2022, participants will gain deeper insights into precision medicine, cancer-stromal interactions, clonal evolution, metastatic dissemination and drug response and resistance.

MAP is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offer the best care to people with cancer worldwide, through oncology education and research.

How can I participate at MAP 2022?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress.

For sponsorship information and a prospectus please contact:

Jon Roberts
Head of Strategic Partnerships

Anna MacDougall
Strategic Projects Manager

We look forward to hearing from you!

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.